Wijziging van de Geneesmiddelenwet ter implementatie van richtlijn 2012/26/EU, wat de geneesmiddelenbewaking betreft

This procedure concerns an amendment to the Medicines Act to implement EU Directive 2012/26/EU. The directive focuses on improving the monitoring of medicines after they have been authorised for use. This change affects the regulatory framework for medicines in the Netherlands, aiming to enhance patient safety by strengthening pharmacovigilance systems and reporting of adverse drug reactions.